Server:Microsoft-IIS/7.5...
X-Powered-By:ASP.NET
The main IP address: alliancepharma.,Your server , ISP: TLD:uk CountryCode:
The description :our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients...
This report updates in 15-Jun-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host alliancepharma.co.uk. Currently, hosted in and its service provider is .
Latitude: | |
Longitude: | |
Country: | () |
City: | |
Region: | |
ISP: |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/7.5 containing the details of what the browser wants and will accept back from the web server.
X-AspNet-Version: | 4.0.30319 |
Content-Encoding: | deflate |
Set-Cookie: | CMSCsrfCookie=nnMT1RV6s24ITkrYiKf+JASH5vr4I5cTiuLR9tzh; path=/; HttpOnly, ASP.NET_SessionId=b4j2w0q1s1xocucwlqxh14c2; path=/; HttpOnly, CMSPreferredUICulture=; expires=Thu, 15-Jun-2017 15:46:21 GMT; path=/; HttpOnly |
Content-Length: | 25613 |
Expires: | -1 |
Vary: | Accept-Encoding |
X-Powered-By: | ASP.NET |
Server: | Microsoft-IIS/7.5 |
X-UA-Compatible: | IE=Edge |
Pragma: | no-cache |
Cache-Control: | no-cache, no-store, must-revalidate |
Date: | Fri, 15 Jun 2018 15:46:20 GMT |
X-Frame-Options: | SAMEORIGIN |
Content-Type: | text/html; charset=utf-8 |
soa: | master-ns.eclipse.net.uk. hostmaster.eclipse.net.uk. 2018060601 7200 1800 86400 86400 |
txt: | "v=spf1 include:_netblocks.mimecast.com ~all" |
ns: | dns1.as12513.net. dns1.eclipse.net.uk. dns2.as12513.net. |
mx: | MX preference = 10, mail exchanger = eu-smtp-inbound-1.mimecast.com. MX preference = 11, mail exchanger = eu-smtp-inbound-2.mimecast.com. |
contact accessibility terms & conditions en current country and language: united kingdom | english (en) china - english germany - deutsche - english ireland - english italy - english - italiano spain - english - español united kingdom - english you are leaving the current language i accept search about us our board vision and values our history working at alliance csr anti-slavery statement contact us business development acquisitions in licensing business development team contact us products therapy areas a - z of products supply news contact us global ireland france germany italy spain china distribution partners investors latest results financial summary reports and presentations share price centre regulatory news financial calendar major shareholders agm advisers and registrars governance analyst coverage inheritance tax aim rule 26 ir contacts share fraud warning investor alerts news financial news media kit contact us contact find us breathing life into medicines investing in our people going for global growth reaching new heights investors share price 101.00 gbp -0.50 -0.49% all data at least 15 min delayed financial news & investor update 07 jun 2018 positive opinion on diclectin 24 may 2018 agm statement 27 mar 2018 aph full year results investor relations financial summary about kelo-cote® about macushield® vamousse® our vision and values to breathe life into medicines around the world... more latest company report latest news positive opinion on diclectin 07th jun 2018 agm statement 24th may 2018 aph full year results 27th mar 2018 vacancies we are recruiting. please find below our current vacancies: follow us on linkedin to avoid missing our next exciting opportunity or send us your cv quality officer 29th mar 2018 senior vigilance associate 16th feb 2018 medical information associate 16th feb 2018 alliance pharma plc avonbridge house bath road chippenham wiltshire sn15 2bb united kingdom tel: +44 [0]1249 466966 fax: +44 [0]1249 466977 email: [email protected] investor relations: [email protected] business development: [email protected] international: [email protected] alliance pharma plc registered office, chippenham registered in england company number 04241478 alliance pharmaceuticals limited registered office as above registered in england company number 03250064 © 2018 alliance pharma. page ref: al/2041/09.15/0.001 date of preparation: october 2015 terms & conditions accessibility news terms of use you are leaving our website you have clicked on a link that will take you to a third-party website that alliance pharma is not responsible for. please read the following disclaimer and click "i agree" to proceed to the third-party website. by clicking to continue you agree that: you are leaving the alliance pharma website. the link to the third-party website is provided as a convenience to our visitors. alliance pharma is not responsible for the content or accuracy of the third-party website nor do we endorse or guarantee any services or information they may offer. alliance pharma does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction. the privacy and security policies of the third-party website may differ from those practiced by alliance pharma. furthermore, alliance pharma' privacy and security policies do not apply to third-party websites. please consult the privacy and security policies on the third-party website you are visiting for further information. i accept
http://investors.alliancepharmaceuticals.com/analyst-coverage
http://investors.alliancepharmaceuticals.com/warning-to-shareholders
https://alliancepharmaceuticals.com/en-gb/home//en-gb/business-development/business-development-team
https://alliancepharmaceuticals.com/en-gb/home//about/working-at-alliance/current-vacancies/quality-officer
https://alliancepharmaceuticals.com/en-gb/home//en-gb/about/working-at-alliance
https://alliancepharmaceuticals.com/en-gb/home//en-gb/global/distributionpartners
https://alliancepharmaceuticals.com/en-gb/home//news/2018/march/aph-full-year-results
https://alliancepharmaceuticals.com/en-gb/home//ap-external-macushield
https://alliancepharmaceuticals.com/en-gb/home//en-gb/accessibility
https://alliancepharmaceuticals.com/en-gb/home//en-gb/products/supply-news
https://alliancepharmaceuticals.com/en-gb/home/business-development
https://alliancepharmaceuticals.com/en-gb/home//en-gb/about/our-board
https://alliancepharmaceuticals.com/en-gb/home//about/working-at-alliance/current-vacancies/medical-information-associate
https://alliancepharmaceuticals.com/en-gb/home//en-gb/products/therapy-areas
https://alliancepharmaceuticals.com/en-gb/home//news
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Error for "alliancepharma.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 157 seconds
WHOIS lookup made at 16:39:50 13-Jul-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS alliancepharma.co.uk
PORT 43
TYPE domain
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME alliancepharma.co.uk
NSERVER
DNS1.AS12513.NET 212.104.130.11
DNS1.ECLIPSE.NET.UK 212.104.129.11
DNS2.AS12513.NET 212.104.130.67
The following list shows you to spelling mistakes possible of the internet users for the website searched .